Thoroughbred Stewards Inquiry Trainer Mr Justin Warwick – Material Man
RWWA Stewards have been advised by the ChemCentre in Perth, that Flunixin has been detected in the blood sample taken from MATERIAL MAN at Belmont Trials on 12 November 2018 where it competed in and won Trial 13.
Flunixen is classed as a therapeutic, non-steroidal anti-inflammatory drug (NSAID).
These findings have been verified by Racing Analytical Services Ltd (Vic).
Accordingly Stewards will conduct an inquiry into this report on Wednesday 2 January 2019 which trainer Mr J. Warwick has been directed to attend.